Skip to main content

Table 8 The clinicopathological features with different stage in PESC

From: The alterations of cytokeratin and vimentin protein expressions in primary esophageal spindle cell carcinoma

 

Number

Stage (%)

χ 2

P

I(n = 29)

II(n = 37)

III(n = 16)

Age

  < 60 years

26

7 (26.9)

14 (53.8)

5 (19.3)

1.41

0.494

  ≥ 60 years

56

22 (39.3)

23 (41.1)

11 (19.6)

Gender

 Male

57

21 (36.8)

25 (43.9)

11 (19.3)

0.19

0.911

 Female

25

8 (32.0)

12 (48.0)

5 (20.0)

Family history

 Positive

18

6 (33.3)

9 (50.0)

3 (16.7)

0.25

0.885

 Negative

64

23 (35.9)

28 (43.8)

13 (20.3)

Smoking

 Yes

41

15 (36.6)

17 (41.5)

9 (21.9)

0.53

0.768

 No

41

14 (34.1)

20 (48.8)

7 (17.1)

Alcohol

 Yes

36

11 (30.6)

15 (41.7)

10 (27.7)

2.84

0.242

 No

46

18 (39.1)

22 (47.8)

6 (13.1)

Tumor location

 Upper

3

1 (33.3)

2 (66.7)

0 (0.0)

1.17

0.960

 Middle

54

19 (35.2)

23 (42.6)

12 (22.2)

 Lower

25

9 (36.0)

12 (48.0)

4 (16.0)

Gross appearance

 Polypoid

69

25 (36.2)

30 (43.5)

14 (20.3)

5.21

0.221

 Ulcerative

8

4 (50.0)

4 (50.0)

0 (0.0)

 Infiltrating

5

0 (0.0)

3 (60.0)

2 (40.0)

Lymph node metastasis

 Yes

23

1 (4.3)

7 (30.4)

15 (65.3)

42.27

0.000

 No

59

28 (47.5)

30 (50.8)

1 (1.7)